Mitsubishi UFJ Trust & Banking Corp Trims Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Mitsubishi UFJ Trust & Banking Corp cut its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 8.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 559,292 shares of the healthcare conglomerate’s stock after selling 51,295 shares during the quarter. UnitedHealth Group accounts for approximately 0.7% of Mitsubishi UFJ Trust & Banking Corp’s holdings, making the stock its 17th biggest position. Mitsubishi UFJ Trust & Banking Corp owned approximately 0.06% of UnitedHealth Group worth $282,923,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. NewSquare Capital LLC purchased a new stake in shares of UnitedHealth Group in the fourth quarter valued at approximately $25,000. AlphaMark Advisors LLC acquired a new position in shares of UnitedHealth Group during the 4th quarter worth $30,000. Promus Capital LLC acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at about $32,000. RPg Family Wealth Advisory LLC acquired a new position in UnitedHealth Group during the third quarter worth about $37,000. Finally, Pillar Financial Advisors LLC acquired a new stake in shares of UnitedHealth Group during the 4th quarter valued at approximately $40,000. 87.86% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The stock was bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now owns 4,500 shares in the company, valued at $2,302,065. This represents a 28.57 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. 0.33% of the stock is currently owned by corporate insiders.

UnitedHealth Group Stock Performance

Shares of NYSE:UNH opened at $516.94 on Tuesday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The firm has a market capitalization of $472.85 billion, a PE ratio of 33.35, a P/E/G ratio of 1.37 and a beta of 0.62. The business has a 50-day moving average of $509.71 and a two-hundred day moving average of $546.15.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. During the same period in the previous year, the firm earned $5.83 earnings per share. UnitedHealth Group’s revenue for the quarter was up 6.8% on a year-over-year basis. As a group, research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were paid a $2.10 dividend. The ex-dividend date was Monday, March 10th. This represents a $8.40 annualized dividend and a dividend yield of 1.62%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.19%.

Analysts Set New Price Targets

Several research firms recently weighed in on UNH. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Truist Financial decreased their price objective on shares of UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. KeyCorp restated an “overweight” rating and set a $650.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. Stephens raised their price objective on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research note on Thursday, December 5th. Finally, Hsbc Global Res upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Friday, January 10th. Twenty investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and a consensus target price of $629.32.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.